EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-17.08%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.72B
AUM Growth
-$541M
(-24%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
20.3%
Holding
982
New
34
Increased
134
Reduced
120
Closed
36
Top Buys
| 1 |
Marriott International Class A Common Stock
MAR
|
$13.5M |
| 2 |
IQVIA
IQV
|
$13M |
| 3 |
Darden Restaurants
DRI
|
$12M |
| 4 |
Gilead Sciences
GILD
|
$7.13M |
| 5 |
Coterra Energy
CTRA
|
$6.7M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
$29.9M |
| 2 |
Biogen
BIIB
|
$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.2M |
| 4 |
CVS Health
CVS
|
$23.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$20.9M |
Sector Composition
| 1 | Healthcare | 27.96% |
| 2 | Technology | 23.65% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Financials | 9.02% |
| 5 | Communication Services | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Pacira BioSciences
PCRX
$1.19B
| $485K | 0.03% |
14,400
| – | – |
|
302
Reinsurance Group of America
RGA
$12.8B
| $478K | 0.03% |
5,500
| – | – |
|
303
Analog Devices
ADI
$122B
| $455K | 0.03% |
5,000
| – | – |
|
304
Fortinet
FTNT
$60.4B
| $449K | 0.03% |
22,880
+19,380
| +554% | +$381K |
|
305
ConocoPhillips
COP
$116B
| $448K | 0.03% |
15,300
-1,600
| -9% | -$46.9K |
|
306
Openlane
KAR
$3.09B
| $444K | 0.03% |
37,000
-218,000
| -85% | -$2.62M |
|
307
Regenxbio
RGNX
$490M
| $439K | 0.03% |
13,000
| – | – |
|
|
QIWI
308
DELISTED
QIWI PLC
QIWI
| $428K | 0.02% |
40,000
| – | – |
|
309
Cheniere Energy
LNG
$51.8B
| $423K | 0.02% |
13,000
+2,100
| +19% | +$68.3K |
|
310
Phillips 66
PSX
$53.2B
| $413K | 0.02% |
+7,620
| New | +$413K |
|
311
TJX Companies
TJX
$155B
| $404K | 0.02% |
8,500
| – | – |
|
312
Motorola Solutions
MSI
$79.8B
| $400K | 0.02% |
3,000
+1,000
| +50% | +$133K |
|
313
American Express
AXP
$227B
| $388K | 0.02% |
4,300
-46,700
| -92% | -$4.22M |
|
314
Ormat Technologies
ORA
$5.51B
| $373K | 0.02% |
5,880
| – | – |
|
315
Align Technology
ALGN
$10.1B
| $356K | 0.02% |
2,026
+1,331
| +192% | +$234K |
|
316
EOG Resources
EOG
$64.4B
| $346K | 0.02% |
9,900
+1,560
| +19% | +$54.6K |
|
317
Tyson Foods
TSN
$20B
| $325K | 0.02% |
5,500
| – | – |
|
318
Enanta Pharmaceuticals
ENTA
$189M
| $314K | 0.02% |
6,200
| – | – |
|
319
Travelers Companies
TRV
$62B
| $308K | 0.02% |
3,000
-1,500
| -33% | -$154K |
|
320
B2Gold
BTG
$5.52B
| $294K | 0.02% |
+95,000
| New | +$294K |
|
321
Air Products & Chemicals
APD
$64.5B
| $289K | 0.02% |
1,400
-3,330
| -70% | -$688K |
|
|
Y
322
DELISTED
Alleghany Corporation
Y
| $283K | 0.02% |
500
| – | – |
|
323
Goosehead Insurance
GSHD
$2.11B
| $274K | 0.02% |
6,000
-39,500
| -87% | -$1.81M |
|
324
Editas Medicine
EDIT
$248M
| $263K | 0.02% |
13,000
| – | – |
|
325
American Financial Group
AFG
$11.6B
| $250K | 0.01% |
3,500
| – | – |
|